- Home
- LFVN vs NGNE Comparison
LFVN vs NGNE Comparison
Compare LFVN & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- NGNE
- Stock Information
- Founded
- LFVN N/A
- NGNE 2003
- Country
- LFVN United States
- NGNE United States
- Employees
- LFVN N/A
- NGNE N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- LFVN Health Care
- NGNE Health Care
- Exchange
- LFVN Nasdaq
- NGNE Nasdaq
- Market Cap
- LFVN 269.4M
- NGNE 230.0M
- IPO Year
- LFVN N/A
- NGNE N/A
- Fundamental
- Price
- LFVN $16.69
- NGNE $17.36
- Analyst Decision
- LFVN Strong Buy
- NGNE Strong Buy
- Analyst Count
- LFVN 2
- NGNE 6
- Target Price
- LFVN $30.50
- NGNE $60.80
- AVG Volume (30 Days)
- LFVN 347.2K
- NGNE 277.9K
- Earning Date
- LFVN 02-05-2025
- NGNE 11-18-2024
- Dividend Yield
- LFVN 0.96%
- NGNE N/A
- EPS Growth
- LFVN 139.37
- NGNE N/A
- EPS
- LFVN 0.56
- NGNE N/A
- Revenue
- LFVN $212,152,000.00
- NGNE $925,000.00
- Revenue This Year
- LFVN $21.53
- NGNE N/A
- Revenue Next Year
- LFVN $8.48
- NGNE N/A
- P/E Ratio
- LFVN $29.66
- NGNE N/A
- Revenue Growth
- LFVN 0.57
- NGNE N/A
- 52 Week Low
- LFVN $5.22
- NGNE $14.42
- 52 Week High
- LFVN $27.38
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- LFVN 36.84
- NGNE 44.25
- Support Level
- LFVN $16.63
- NGNE $16.72
- Resistance Level
- LFVN $19.28
- NGNE $19.97
- Average True Range (ATR)
- LFVN 2.03
- NGNE 2.39
- MACD
- LFVN -0.60
- NGNE 0.08
- Stochastic Oscillator
- LFVN 8.79
- NGNE 19.43
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.